Mannheim, Germany

Gunther Neugebauer

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Mannheim Gmbh. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gunther Neugebauer. Retrieved from https://idiyas.com/inventor/gunther-neugebauer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gunther Neugebauer: Innovator in Bioavailability

Introduction

Gunther Neugebauer is a notable inventor based in Mannheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in enhancing drug formulations. His work focuses on improving the bioavailability of medications, which is crucial for effective treatment outcomes.

Latest Patents

Gunther Neugebauer holds a patent for a tablet with improved bioavailability. This innovation aims to enhance the absorption and effectiveness of the active ingredients in the medication, thereby providing better therapeutic results for patients.

Career Highlights

Throughout his career, Gunther Neugebauer has been associated with Boehringer Mannheim GmbH, a leading company in the pharmaceutical industry. His expertise in drug formulation and development has been instrumental in advancing the company's product offerings.

Collaborations

Gunther has collaborated with esteemed colleagues such as Walter Preis and Bernd Musel. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Gunther Neugebauer's contributions to the field of pharmaceuticals, particularly through his patent for a tablet with improved bioavailability, highlight his role as an influential inventor. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…